West Pharmaceutical Services, Inc.
WST
$301.88
-$10.19-3.27%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 542.70M | 493.70M | 491.70M | 487.70M | 467.20M |
| Total Depreciation and Amortization | 176.60M | 171.40M | 165.10M | 162.30M | 159.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.20M | 9.90M | 15.40M | 7.30M | 0.00 |
| Change in Net Operating Assets | -23.20M | 79.80M | 21.60M | 19.40M | 37.60M |
| Cash from Operations | 715.30M | 754.80M | 693.80M | 676.70M | 664.60M |
| Capital Expenditure | -257.30M | -285.90M | -314.70M | -332.70M | -357.70M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00K | -700.00K | -1.70M |
| Cash from Investing | -257.30M | -285.90M | -314.60M | -333.40M | -359.40M |
| Total Debt Issued | -- | -- | 0.00 | 129.70M | 164.70M |
| Total Debt Repaid | -1.20M | -1.10M | -900.00K | -133.80M | -191.80M |
| Issuance of Common Stock | 21.30M | 18.20M | 16.70M | 18.70M | 20.30M |
| Repurchase of Common Stock | -300.90M | -136.80M | -191.20M | -243.50M | -430.20M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -61.80M | -61.20M | -60.70M | -60.10M | -59.60M |
| Other Financing Activities | -4.20M | -4.20M | -6.20M | -6.20M | -2.00M |
| Cash from Financing | -346.80M | -185.10M | -242.30M | -295.20M | -498.60M |
| Foreign Exchange rate Adjustments | 6.00M | 22.90M | 700.00K | 15.40M | -4.20M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.20M | 306.70M | 137.60M | 63.50M | -197.60M |